OTCMKTS:ORINY Orion OYJ (ORINY) Stock Price, News & Analysis $37.99 0.00 (0.00%) As of 05/15/2026 Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartDividendEarningsHeadlinesShort InterestBuy This Stock About Orion OYJ Stock (OTCMKTS:ORINY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Orion OYJ alerts:Sign Up Key Stats Today's Range$37.99▼$37.9950-Day Range$37.86▼$41.0452-Week Range$25.95▼$42.75VolumeN/AAverage Volume14 shsMarket Capitalization$10.72 billionP/E Ratio17.43Dividend Yield1.00%Price TargetN/AConsensus RatingHold Company Overview Orion Corporation (Orion Oyj) is a Finland-based pharmaceutical company engaged in the research, development, manufacture and marketing of human and veterinary medicines as well as diagnostic tests. The company’s core therapeutic areas include central nervous system disorders, oncology and respiratory diseases, and it offers both proprietary and generic products. Orion’s product range spans from small-molecule drugs and active pharmaceutical ingredients to radiodiagnostic imaging agents and line extensions developed through in-house research. Since its founding in 1917 in Helsinki, Orion has grown into an integrated pharmaceuticals business with state-of-the-art manufacturing facilities in Finland and France. The company’s R&D organization focuses on novel chemical entities and life-cycle management of existing products, supported by a network of research partnerships and licensing agreements. In addition to human healthcare, Orion Diagnostica develops and distributes immunoassays and point-of-care tests for clinical and veterinary diagnostics. Orion serves markets across Europe, the Nordic countries and selected regions in Asia and Latin America, leveraging both direct sales operations and partner networks. The company maintains strategic alliances to expand its geographic reach and enhance market access for its specialty products. Orion’s customer base includes hospitals, pharmacies and healthcare professionals, reflecting its long-established presence in the pharmaceutical industry.AI Generated. May Contain Errors. Read More Receive ORINY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Orion OYJ and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ORINY Stock News HeadlinesOrion Oyj Record 2025 Results Put Board Changes And Valuation In FocusFebruary 15, 2026 | finance.yahoo.comDoes Orion Oyj (HLSE:ORNBV) Dividend Hike Clarify Its Oncology-Pivot Capital Allocation Strategy?February 14, 2026 | finance.yahoo.comElon Musk’s $1 Quadrillion AI IPO$1 quadrillion would be enough to send a $2.8 million check to every man, woman, and child in America. That is the scale of what analysts are calling the biggest AI IPO in history.And right now, you can claim a stake before the company goes public, starting with just $500.Elon Musk is predicting this investment could climb 1,000x from here. Early access is available today.May 17 at 1:00 AM | Brownstone Research (Ad)Orion Oyj (ORINY) Q4 2025 Earnings Call Highlights: Record Growth and Strategic DevelopmentsFebruary 12, 2026 | finance.yahoo.comAssessing Orion Oyj (HLSE:ORNBV) Valuation After A Strong 1 Year Shareholder ReturnFebruary 7, 2026 | finance.yahoo.comOrion publishes Financial Statement Release for 2025 and holds a webcast on 12 February 2026January 30, 2026 | uk.finance.yahoo.comAssessing Whether Orion Oyj (HLSE:ORNBV) Justifies Its Premium P/E After Strong Recent ReturnsJanuary 15, 2026 | finance.yahoo.comOrion updates time estimate for the potential related to the annual Nubeqa® net sales recorded by OrionJanuary 15, 2026 | finance.yahoo.comSee More Headlines ORINY Stock Analysis - Frequently Asked Questions How have ORINY shares performed this year? Orion OYJ's stock was trading at $36.8425 at the beginning of the year. Since then, ORINY stock has increased by 3.1% and is now trading at $37.9875. How were Orion OYJ's earnings last quarter? Orion OYJ Unsponsored ADR (OTCMKTS:ORINY) posted its quarterly earnings results on Thursday, April, 23rd. The company reported $0.37 earnings per share for the quarter. The firm had revenue of $488.80 million for the quarter. Orion OYJ had a net margin of 27.14% and a trailing twelve-month return on equity of 50.01%. How do I buy shares of Orion OYJ? Shares of ORINY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings4/23/2026Today5/17/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED - DRUGS Sub-IndustryN/A Current SymbolOTCMKTS:ORINY Previous SymbolNASDAQ:ORINY CIKN/A Webwww.orion.fi Phone358 10 4261FaxN/AEmployees4,029Year FoundedN/AProfitability EPS (Trailing Twelve Months)$2.18 Trailing P/E Ratio17.43 Forward P/E RatioN/A P/E GrowthN/ANet Income$566.04 million Net Margins27.14% Pretax Margin33.23% Return on Equity50.01% Return on Assets29.82% Debt Debt-to-Equity Ratio0.09 Current Ratio2.40 Quick Ratio1.58 Sales & Book Value Annual Sales$2.14 billion Price / Sales5.02 Cash Flow$2.23 per share Price / Cash Flow17.02 Book Value$5.15 per share Price / Book7.38Miscellaneous Outstanding Shares282,270,000Free FloatN/AMarket Cap$10.72 billion OptionableNot Optionable Beta0.09 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.Get This Free Report This page (OTCMKTS:ORINY) was last updated on 5/17/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredSpaceX Goes Public. Here's What Happens To Your IRA.When SpaceX goes public, fund managers will sell existing portfolio holdings to fund the move. Trillions in as...Americas Gold Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orion OYJ Unsponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Orion OYJ With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
